Previous studies have shown an increasing trend in LVAD-specific infections among LVAD recipients receiving immunosuppressive therapy, but the small number of cases leaves room for discussion. 13 A key point of concern is that some infections may remain occult or manifest atypically under immunosuppression, delaying diagnosis and treatment.
← all excerpts
Infectious complications and transplant outcomes in durable left ventricular assist device patients receiving immunosuppressive therapy: case series.
1
—
—